| ²é¿´: 581 | »Ø¸´: 0 | |||
secwhiteгæ (³õÈëÎÄ̳)
|
[½»Á÷]
ÕÐÊÕ postdocs, PhD/MS graduate students£¨»¯Ñ§¡¢²ÄÁÏ¡¢ÉúÎï·½Ïò£©
|
|
µ¼Ê¦¼ò½é£º Dr. Zhu is an NIH KL2 scholar (2019-2021) and Assistant Professor of Pharmaceutics at VCU. He received his BS (2008) in Biotechnology from Nankai University, China, and completed Ph.D. (2013) in Medical Sciences at the University of Florida College of Medicine. Dr. Zhu was a postdoc at NIBIB/NIH. His research interests lie at the interface of immune-oncology, nucleic acid therapeutics, nanomedicine, pharmacoengineering and pharmacoimaging. Ñо¿·½Ïò£º Our research interests lie at the interface of immune-oncology, nucleic acid theranostics, immunotherapy, and functional biomaterials. My current focus is to develop therapeutics and vaccines for combination cancer immunotherapy, infectious disease prevention, and drug abuse treatment. Current primary research directions are listed below. 1. mRNA vaccines for cancer immunotherapy and infectious disease prophylaxis. 2. Novel nucleic acid immunotherapeutics for cancer immunotherapy (immunomodulatory DNA/RNA, mRNA, gene-editing gRNA, siRNA, aptamer) 3. ADAR-targeted nucleic acid theranostics and immunomodulators 4. Drug and vaccine delivery 5. Biomaterials: Nanovaccine/Nanomedicine, polymer microneedle patches, hydrogel ÁªÏµ·½Ê½£º Email: gzhu2@vcu.edu or zhu.julian21@gmail.com Wechat: Guizhi_Zhu Website: https://guizhizhu.org »¶Ó¸ÐÐËȤµÄÅóÓÑ×ÉѯºÍͶµÝ¼òÀúÖÁDr. ZhuÓÊÏä»ò΢ÐÅÁªÏµ£¬»òÕ¾ÄÚÁªÏµÎÒ¡£Ð»Ð»´ó¼Ò£¡ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : Postdoc_Grad_Ad_Zhu.pdf
2022-11-18 07:43:57, 117.98 K
» ²ÂÄãϲ»¶
Ó¢ÎÄ×ÛÊöÊÇ·ñÐèÒªÈóÉ«¼°²éÖØ
ÒѾÓÐ5È˻ظ´
¾ÈÃüÌû
ÒѾÓÐ5È˻ظ´
ÏÞÏî¹æ¶¨
ÒѾÓÐ5È˻ظ´
ΪʲônbsÉÏäå ûÓвúÎïµã³öÏÖÄØ
ÒѾÓÐ9È˻ظ´
Õв©Ê¿
ÒѾÓÐ3È˻ظ´
´æ¿î400Íò¿ÉÒÔÔÚѧУÀïÌÉÆ½Âð
ÒѾÓÐ35È˻ظ´
×îʧÍûµÄÒ»Äê
ÒѾÓÐ18È˻ظ´
ÇóÍÆ¼öÓ¢ÎÄEIÆÚ¿¯
ÒѾÓÐ5È˻ظ´













»Ø¸´´ËÂ¥